NIMH Outreach Partnership

NAMI New Jersey is one of the 55 Outreach Partner organizations of the National Institute of Mental Health (NIMH) to conduct mental health outreach and education for the public, health professionals, K-12 schools, minorities and other populations such as youth and older adults using mental health-related information provided by NIMH or other sources.

The NIMH Outreach Partnership Program is a nationwide initiative of the National Institute of Mental Health (NIMH) with support from the National Institute on Drug Abuse (NIDA) and in cooperation with the Substance Abuse and Mental Health Services Administration (SAMHSA). The Program partners with national and state organizations to strengthen the public health impact of research by disseminating the latest scientific findings; informing the public about mental disorders, alcoholism, and drug addiction; and reducing the associated stigma and discrimination. The Program strives to increase public awareness about the important role of basic and clinical research in transforming the understanding and treatment of mental illnesses and addiction disorders, paving the way for prevention, recovery, and cure. The Program also provides NIMH with the opportunity to engage community organizations in a dialogue to help develop a national research agenda to improve America’s mental health.

 

NIMH LATEST UPDATE (June 2019)

Click here to subscribe to receive the update every two weeks

Click to view Presentation on Searching ClinicalTrials.gov

Click to Read the Director’s Message

 

Clinical Trial Participation Update

Find Clinical Trials by State:

http://www.clinicaltrials.gov/ct2/results/map/click?term=Behaviors+and+Mental+Disorders%5BCONDITION-BROWSE-BRANCH%5D&recr=Open&fund=01&map.x=163&map.y=177

For more information on research conducted by NIMH in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

 

Nationwide Recruitment: NIMH Study

Depression and Brain Function

(Inpatient and/or Outpatient study: 8 weeks, and 3 once-a-month follow up visits or phone calls.) This depression research study tests the effects of the combination of transcranial magnetic stimulation (TMS) and psychotherapy on brain function. Participation includes research evaluations, brain scans, and active TMS and psychotherapy, or inactive TMS and psychotherapy.  Recruiting ages 18-65 with major depressive disorder, who are free of other serious medical conditions. If you are currently taking anti-depressants, you may still be eligible. (17-M-0147). Call: 1-877-MIND-NIH, (1-877-646-3644), TTY: 1-877-411-1010, email moodresearch@mail.nih.gov, National Institutes of Health, National Institute of Mental Health, Protocol #17-M-0147.

https://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/adult-studies/depression-tms-psychotherapy-and-brain-function.shtml

 

Understanding Depression in Teenagers

NATIONWIDE RECRUITMENT—NIH RESEARCH: DEPRESSION IN TEENAGERS Join a research study seeking to find causes and treatments of depression in teenagers. The study is recruiting participants ages 11-17 who are depressed and have a pediatrician or medical provider. The study begins with an outpatient evaluation (clinical assessment, interviews, and questionnaires). Outpatient study visits include a clinical assessment, research tasks, and brain imaging, up to age 25. Eligible participants may receive treatment of evidence-based cognitive-behavioral therapy and, if indicated, standard medicines. Enrollment is from across the U.S. Transportation expenses to NIH in Bethesda, MD are reimbursed. There is no cost to participate; compensation is provided.

Call 1-301-827-1350 [TTY: 1-866-411-1010] or Email depressedkids@mail.nih.gov. www.nimh.nih.gov/TeenDepressionStudy

Department of Health & Human Services, National Institutes of Health, National Institute of Mental Health, Protocol Number: 18-M-0037

 

Nationwide Recruitment: Descriptive Study of Severe Irritability

(Outpatient: One-day evaluation, and may include follow-up visits until age 25)

This NIMH study describes, over time, the moods and behavior of children and the associated brain changes. Participants must be in treatment with a physician, medically healthy, and not currently hospitalized, psychotic, or suicidal. Symptoms include chronic anger, sadness, or irritability, along with hyperarousal (such as insomnia, distractibility, hyperactivity), and extreme responses to frustration (such as frequent, severe temper tantrums). The study procedures include research and computer tasks, neuropsychological testing, and brain imaging and is recruiting youth ages 7-17. [02-M-0021]

https://www.nimh.nih.gov/labs-at-nimh/join-a-study/children/children-irritability.shtml

 

Nationwide Recruitment: Depression and Brain Function

(Inpatient and/or Outpatient study: 8 weeks, and 3 once-a-month follow up visits or phone calls.) This depression research study tests the effects of the combination of transcranial magnetic stimulation (TMS) and psychotherapy on brain function. Participation includes research evaluations, brain scans, and active TMS and psychotherapy, or inactive TMS and psychotherapy.  Recruiting ages 18-65 with major depressive disorder, who are free of other serious medical conditions. If you are currently taking anti-depressants, you may still be eligible. (17-M-0147). Call: 1-877-MIND-NIH, (1-877-646-3644), TTY: 1-877-411-1010, email moodresearch@mail.nih.gov, National Institutes of Health, National Institute of Mental Health, Protocol #17-M-0147.

https://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/adult-studies/depression-tms-psychotherapy-and-brain-function.shtml

Depression Evaluations for Medication and Brain Imaging Studies

This study screens for various inpatient and outpatient studies that investigate the brain and experimental medications (such as ketamine and AV101) to quickly lift severe and hard-to-treat depressive symptoms.

Participation may include outpatient visits or inpatient stays lasting 4 to 12 weeks at the NIH Clinical Center, Bethesda, MD. Procedures may include: tapering off current psychiatric medications, a medication-free period, oral or intravenous medication versus placebo, and brain scans. You may also qualify for other studies that have different requirements and lengths of stay.

Participants must be ages 18-70 and free of serious medical conditions. These studies may enroll eligible participants from across the USA. Travel arrangements and compensation are provided. There is no cost to participate.

First steps to participate include, calling NIMH, learning study details, asking about your eligibility, and consenting to participate.

To find out if you qualify, email NIMH or call 1-877-646-3644 (1-877-MIND-NIH) [TTY: 1-866-411-1010].

 

 

Worry A Lot, Anxious, Shy, or Nervous in Social Situations?

Local Recruitment (Washington, D.C., Maryland, and Virginia)

This study seeks to better understand anxiety by examining changes in emotional reaction and task performance under stress. We want to understand the way these changes are different for people suffering from anxiety or mood disorders.

Participants must be 18 to 60, with generalized anxiety disorder, social anxiety disorder or a panic disorder. Participants must be free of certain medical conditions and currently not on psychiatric medications.

You may not be eligible if you are pregnant, have current alcohol or substance abuse problems, heart disease, neurological disease, or any health problems that would interfere with the study or make it unsafe for you.

Research procedures will include:  a screening visit, 1 to 2 outpatient visits, computer tasks, exposure to unpleasant stimuli. Researchers will assess changes in heart rate, muscle activity, sweat responses and respiration. Visits may last up to 4 hours each.

This study is conducted at the NIH Clinical Center, Bethesda, MD.Compensation is provided.

To find out if you qualify or for more information:  email anxiety@mail.nih.gov, or call 1-888-644-2694, TTY: 1-866-411-1222,

http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/adult-studies/predictability-and-aversive-expectancies-in-anxiety-disorders.shtml

Today’s Research on Medicines for Children Offers Hope for Tomorrow

Only 25 years ago, it was rare to find drug labels with dispensing information specific to children. That’s because pharmaceutical companies rarely, if ever, conducted the research necessary to develop such instructions. As a result, health care providers often gave children smaller doses of adult medicines, without evidence of how exactly the children would react. This blog post describes Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) activities to lead a nationwide initiative to include infants, children, and adolescents in drug research studies. In addition, it highlights the experiences of two families involved in NICHD-supported pediatric pharmacology research. https://www.nichd.nih.gov/news/resources/spotlight/Pages/012615-pharmacology.aspx

Join NIH Depression Research Studies
Does depression impede your daily life? Are you currently feeling sad and hopeless, experiencing worthlessness and guilt, and have a lack of interest in everyday activities you once enjoyed? NIH studies are investigating the brain and experimental medications (such as ketamine and diazoxide) to rapidly reduce depressive symptoms.  Research includes: depressed adults ages 18 to 70, outpatient visits or inpatient stays of up to 12 weeks at the NIH Clinical Center in Bethesda, MD.  Call 1-877-MIND-NIH, TTY: 1-866-411-1010. Email: moodresearch@mail.nih.gov

http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/adult-studies/depression-evaluations-for-medication-and-brain-imaging-studies.shtml

Bipolar Disorder (Pediatric) Research Study: Treatment of Severe Mood Dysregulation
(Inpatient: 12-15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy, and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]

http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-bpd.shtml

For more information on research conducted by NIMH in Bethesda, MD click here: www.nimh.nih.gov/JoinAStudy.

 

Nationwide Recruitment: Bipolar Disorder, Pediatric Research Study
Treatment of Severe Mood Dysregulation (SMD)

(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-irritability.shtml

 

Nationwide Recruitment: NIH BIPOLAR DEPRESSION RESEARCH STUDIES ENROLLING PARTICIPANTS
IS YOUR BIPOLAR DEPRESSION HARD TO TREAT?
EXPERIENCING THOUGHTS OF SADNESS, HOPELESSNESS, GUILT, WORTHLESSNESS, LACKING INTEREST IN EVERYDAY ACTIVITIES YOU ONCE ENJOYED?
NIH researchers seek people between the ages of 18 and 70 with bipolar disorder, who are currently in a depressive phase, for participation in several brain imaging and medication studies that are evaluating how experimental medications (ketamine, riluzole, and scopolamine) may reduce symptoms rapidly. Participation includes one to four visits to the NIH Clinical Center in Bethesda, MD, psychiatric interviews, medical history, physical exam, and blood and other medical tests. Some studies are conducted on an outpatient basis, others on an inpatient basis. Participants must be free of other serious medical conditions. Research evaluations and medications are provided at no cost.

There is no cost to participate in the studies. NIMH enrolls eligible participants locally and from around the country. Travel arrangements are provided and costs covered by NIMH. (Arrangements vary by distance and by specific study.) After completing the study, participants receive short-term follow-up care while transitioning back to a provider in their community.

Atendemos pacientes de habla hispana.

Call: 1-877-MIND-NIH (1-877-646-3644)
TTY: 1-866-411-1010
E-mail: moodresearch@mail.nih.gov
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/adults/adults-depression.shtml

 

Nationwide Recruitment: NIMH Adult Depression Research Study: Is Your Major Depression Hard to Treat?
This inpatient study is enrolling eligible participants to assess the effectiveness of the oral medication diazoxide versus placebo to rapidly improve hard-to-treat depressive symptoms. Eligibility criteria include people ages 18-65, who are diagnosed with Major Depressive Disorder (MDD), have previously failed to respond to treatment, and who are free of other serious medical conditions. This study can last up to 12 weeks and is conducted at the NIH Clinical Center in Bethesda, Maryland.

There is no cost to participate. We enroll eligible participants locally and from around the country. Travel arrangements are provided and costs are covered by NIMH (arrangements vary by distance). After completing the study, participants receive short-term follow-up care at the NIH while transitioning back to a provider.

For more information, call: 1-877-MIND-NIH (1-877-646-3644), TTY: 1-866-411-1010, or e-mail: moodresearch@mail.nih.gov

Atendemos pacientes de habla hispana.

http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/adult-studies/treatment-resistant-major-depression-and-diazoxide.shtml

 

Participating in Alzheimer’s Research: For Yourself and Future Generations
Participating in Alzheimer’s Research: For Yourself and Future Generations is a new 20-page booklet from NIH. It can help individuals decide if participating in clinical research is right for them, a friend, or a family member. At least 70,000 volunteers are now needed for more than 150 Alzheimer’s and related clinical studies in the U.S. All kinds of people, including healthy older adults, can join in this research. http://www.nia.nih.gov/alzheimers/publication/participating-alzheimers-research

 

 

NIMH Links

NIMH home page
Outreach Partnership Program
Publications and resource
NIMH clinical studies
Find Clinical Trials by State
National Institute of Health (NIH) Clinical Trials – www.clinicaltrials.gov

 

Related Links

Substance Abuse and Mental Health Services Administration (SAMHSA)
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) Publications

 

Multicultural Outreach

As a self-help organization, NAMI NJ is especially sensitive to the concept of mutual caring and responsibility implicit in family relationships and reaching out in that context to families from various cultures that are affected by serious mental illness. NAMI NJ has gained considerable expertise in the area of multi-cultural outreach and program development. AACT-NOW (African American), CAMHOP (Chinese), NAMI En Español (Latino) and SAMHAJ (South Asian) are four NAMI NJ innovative multi-cultural support and education programs that outreach to African American, Chinese, Latino and  South Asian families. The programs also provide education for mental health professionals to help them better understand cultural and treatment issues relevant to these populations.

NAMI NJ Received the 2014 American Psychiatric Foundation Award for Advancing Minority Mental Health

 

See each program below for support group information.

 

AACT-NOW (African American Mental Health Outreach) 

AACT-NOW is a NAMI NJ initiative serving New Jersey’s African American communities which include individuals and families affected by mental illness, the faith community, and mental health professionals. AACT-NOW provides culturally competent support, education and advocacy in the northern, central and southern regions of New Jersey, through free services such as support groups, phone referral, community workshops and other outreach activities.

 

CAMHOP-NJ (Chinese American Mental Health Outreach Program in New Jersey)

CAMHOP-NJ is a NAMI NJ initiative to help people of Chinese origin (including immigrants from mainland China, Hong Kong, Taiwan, and their descendants) in New Jersey gain better understanding about mental illness as a biological based and treatable disease. Our free services include support groups, referral services, advocacy, NAMI Family-to-Family Education Course in Chinese, community workshops, and educational materials in Chinese.

 

NAMI NJ en Español

NAMI NJ en Español is an awareness & education program developed by NAMI NJ serving the Hispanic/Latino community in New Jersey. It offers local self-help support groups, referral services, NAMI Family-to-Family Education Course in Spanish, community workshops, and other outreach activities.

 

SAMHAJ (South Asian Mental Health Awareness in Jersey)

SAMHAJ is a NAMI NJ initiative to help South Asians (of Indian, Pakistani, Bangladeshi, Sri Lankan, Nepali, Afghan and Bhutanese origin) in New Jersey understand that mental illness is a biologically based and treatable illness. Our free services include support groups, referral services, advocacy, community workshops, and other outreach activities. This program won the NAMI 2002 Multicultural Award.

 

NAMI NJ Documentary “Documenting Our Presence: Multicultural Experiences of Mental Illness

Documenting Our Presence: Multicultural Experiences of Mental Illness” was produced in 2007 as a NAMI NJ Multicultural Outreach Initiative with the support of NAMI – National Alliance of Mental Illness and NJ Division of Mental Health Services. This documentary is a compassionate, hopeful look at the experiences of people of diverse backgrounds, affected by serious mental illness. It traces their lives through a cultural lens, focusing on the onset of mental illness, the process of coping and acceptance, and finally, their journey to recovery. To order a copy please visit NAMI NJ Store.

 

Recommended Material:

Health Beliefs Toolkit
Concha, M, Villar, M.E., & Azevedo, L, (2014) Health Attitudes and Beliefs Tool Kit, Technical Assistance Network for Children’s Behavioral Health, University of Maryland, Baltimore, MD.

 

Advocacy E-news October 7, 2019

October 7, 2019

 

NAMI STATEMENT ON RELEASE OF U.S. PRESIDENTIAL CANDIDATE POSITIONS ON MENTAL HEALTH AND ADDICTION

The National Alliance on Mental Illness (NAMI) is a proud member of Mental Health For US, a nonpartisan, educational coalition elevating mental health and addiction in policy conversations around the country. Today, the coalition released candidate responses to their survey which asked 11 questions addressing mental health, drug overdose, criminal justice reform, equal access to care and more.

See the candidates’ positions

 

THE CASE FOR SCREENING STUDENTS FOR ADDICTION, MENTAL HEALTH ISSUES

A school-based program of early intervention has worked in other states. Health advocates and others argue for its widespread adoption in New Jersey. These specific school-based programs, SBIRT, for Screening Brief Intervention, and Referral to Treatment are part of a proven clinical model and are effective and efficient in preventing suicide, substance use disorders and other chronic health problems later in life.

Learn more from NJ Spotlight

 

PELOSI UNVEILS PLAN TO LOWER PRESCRIPTION DRUG COSTS

House Speaker Nancy Pelosi, D-Calif., unveiled her long-anticipated plan to lower the cost of prescription drugs on Thursday. It is a priority shared by President Trump, fueling a glimmer of hope that there is a deal to be had on the issue ahead of the 2020 elections.

Learn more

 

NJ TO PROVIDE $2M TO ASSIST RESIDENTS WITH ACA ENROLLMENT

The New Jersey Department of Banking and Insurance announced on Thursday the state will dedicate up to $2 million in grant funding beyond what the federal government would have provided for state navigators and other organizations to provide enrollment assistance to New Jersey residents shopping for health coverage during this year’s open enrollment period Nov. 1, 2019 to Dec. 15, 2019, as part of the state’s move to a State-Based Exchange on the Federal Platform.

See the full story in NJ BIZ

 
 
 

Advocacy E-News June 5, 2019

June 5, 2019

 

PRETEENS ATTEMPTING SUICIDE IN NJ AT ALARMING RATES

There’s no sugarcoating this one. Preteens attempting to commit suicide by drug overdose has  nearly tripled in New Jersey  over the last eight years, and it’s slated to hit an all-time high this year, according to the data from the New Jersey Poison Control as parsed by Rutgers New Jersey Medical School.

Read more

 

LOOKING TO GET TO GRIPS WITH LONELINESS AMONG NJ’S ELDERLY, OTHERS AT RISK

Amid growing concern worldwide about the impact of loneliness on the elderly, Garden State lawmakers want to learn how social isolation affects vulnerable New Jerseyans and what can be done to keep them more active and engaged. A handful of Democratic legislators introduced a bill earlier this month to create a task force to assess the nature and frequency of social isolation among seniors, and among individuals with disabilities or mental illness, veterans, and other at-risk groups.

Go to the story

 

GRANTS FOR POLICE MENTAL HEALTH OUTREACH PROGRAMS

Improving police responses to people with mental health issues in the community requires collaboration with many agencies, most especially behavioral health service providers. The resources needed to develop and sustain these collaborations often require funding that may not be readily available within a police department’s budget. However, several federal, state and private grant programs will support these projects. Knowing where to look and thinking outside the box can help secure the funding needed to support this valuable work.

Here are a few options to consider.

 

ROCK STAR MET WITH SURVIVORS OF SOLITARY CONFINEMENT IN ASBURY

Rock icon and political activist Tom Morello (Rage Against the Machine, Audioslave, the Nightwatchman) recently met with survivors of solitary confinement in urging New Jersey to stop its use of solitary confinement. Legislation has been introduced in the New Jersey Assembly and Senate, A314/S3261, The Isolated Confinement Restriction Act, which would prohibit the use of solitary confinement in New Jersey correctional facilities for people with a mental illness.

See more

 

FEDERAL BILL INTRODUCED TO ENFORCE MENTAL HEALTH PARITY, HOLD INSURANCE COMPANIES ACCOUNTABLE

U.S. Congressman Donald Norcross (NJ-01), Vice-Chair of the Bipartisan Addiction Task Force, along with U.S. Representatives Joe Courtney (CT-02) and Ann Kuster (NH-02), Chair of the Bipartisan Addiction Task Force, introduced the Parity Enforcement Act, H.R. 2848, which expands the U.S. Department of Labor’s authority to hold health insurers and plan sponsors accountable for offering health plans that violate the Mental Health Parity and Addiction Equity Act of 2008.

Go to the announcement

 
 
 

Advocacy E-news January 2, 2019

January 2, 2019

 

ACTING GOVERNOR SIGNS LEGISLATION TO ESTABLISH THE NEW JERSEY CAREGIVER TASK FORCE

Acting Governor Sheila Oliver on Friday signed legislation to establish the New Jersey Caregiver Task Force, which will evaluate support services that are available to caregivers. The Task Force will also recommend improvements and expansion of such services and is required to provide an initial report within a year of its organization. The Task Force will consist of 11 members from public and private sectors including one person who is a caregiver for a person with a mental illness.

Read the full story

 

N.J. AG TO HOST SERIES OF COMMUNITY FORUMS ON POLICE USE OF FORCE

New Jersey’s attorney general will host a series of forums across the state to address the findings of NJ.com’s recent investigation into police use of force, including a review of cultural diversity and “implicit bias” among officers. The Force Report found the state’s system for tracking use of force and stopping dangerous officers was little more than a facade. The report also found inconsistent reporting of officer’s interactions with people with a mental illness.

Go to the story

See the Force Report

 

IN SCREENING FOR SUICIDE RISK, FACEBOOK TAKES ON TRICKY PUBLIC HEALTH ROLE

Facebook’s rise as a global arbiter of mental distress puts the social network in a tricky position at a time when it is under investigation for privacy lapses. Facebook has computer algorithms that scan the posts, comments and videos of users in the United States and other countries for indications of immediate suicide risk. But other mental health experts said it is unclear whether the company’s approach is accurate, effective or safe.

Read more

 

TIME IS RUNNING OUT FOR FEDERALLY FUNDED MENTAL-HEALTH CLINICS

An experimental mental-health and addiction treatment program that has shown early success in combating the opioid crisis is at risk of losing its federal funding. The experimental program was set up after legislation in 2014 established standards for a new clinic designation called Certified Community Behavioral Health Clinics and created flexible funding that allowed the clinics to expand patient outreach and services for two years.

Learn more

 

CLINIC HELPS VETERANS, FIRST RESPONDERS WITH FREE CARE

Suicide and addiction occur at a staggering rate among first responders and military members, due to post-traumatic stress disorder, coupled with a gaping hole in accessible, appropriate mental health care and a stigma that keeps many of them from seeking help.

Veteran & First Responder (VFR) Healthcare will be offered at the Strive Center and Community Health in Paramus. In partnership with the NJ Department of Military and Veteran Affairs, VFR will offer outpatient, substance-abuse and mental health trauma-informed treatment programs and services designed specifically for Veterans, First Responders, and their families. 

Go to the story